Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bevacizumab|DRUG: cyclophosphamide|DRUG: methotrexate
Sponsor: Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI)|Genentech, Inc.